Category: Pharma News

The NPPA Sets a Price Cap on Nine Planned Formulations, one of which is a Medication for Brain Cancer

Nine more formulations have had their ceiling prices set by the National Pharmaceutical Pricing Authority (NPPA), bringing the total number of formulations notified with updated prices under the Drugs (Prices Control) Order (DPCO), 2013—a revised Schedule I based on the National List of Medicines (NLEM), 2022—to 700.

AIIMS Bhopal Pharmacist Vacancy Cancellation Notice

It is hereby informed that the Advt. No. ADM-2(3)/AIIMS Bhopal/RC/2023/02 dated 25/10/2023 published in the Newspapers on 27/10/2023 and also uploaded on Institute’s website for filling of 357 Group- ‘C’ Non-Faculty Domain Specific Posts of 26 different cadres on Direct Recruitment basis has been cancelled due to administrative reasons. Application fee of Candidate’s who have already applied against this advertisement, shall be refunded.

Union Home Minister Amit Shah unveiled the permanent campus of the National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad in Gandhinagar.

During the inauguration ceremony held at Palaj in Gandhinagar, Minister Shah expressed India’s determination not only to achieve self-sufficiency in drug manufacturing but also to become a global exporter of Active Pharmaceutical Ingredients (API) and Key Starting Materials (KSM) within…

Lupin Acquires Brands ONDERO® and ONDERO MET® to expand Diabetes Portfolio in India

Global pharma major Lupin Limited (Lupin) announced today the acquisition of diabetes brands ONDERO® and ONDERO MET®, from Boehringer Ingelheim International GmbH (Boehringer Ingelheim), including the trademark rights associated with these brands. Lupin has been marketing ONDERO® and ONDERO MET®…

Back to top
WhatsApp Join Telegram